ARHGEF2 and cancer: While GEF–H1 dysregulation has been implicated in cancer metastasis, immune responses, and vascular pathologies [25, 26], key aspects remain underexplored: the compartmentalized signaling of its isoforms, their context‐dependent functional redundancy in disease states, and the therapeutic implications of isoform‐specific regulation.